Pretax income is the income that a company earns before paying income taxes. Perrigo Co's pretax income for the
three
months ended in Dec. 2023 was $-54 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-8 Mil.
Perrigo Co's pretax margin was -4.69%.
During the past 13 years, Perrigo Co's highest Pretax Margin was 7.76%. The lowest was -91.81%. And the median was 4.74%.
Perrigo Co Pre-Tax Income Historical Data
The historical data trend for Perrigo Co's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Perrigo Co's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Pre-Tax Income falls into.
Perrigo Co Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Perrigo Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (NYSE:PRGO) Pre-Tax Income Explanation
Perrigo Co's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Perrigo Co's highest Pretax Margin was 7.76%. The lowest was -91.81%. And the median was 4.74%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRGO has been successfully added to your 